The antibacterial properties of secreted phospholipases A2

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1488, Issue 1-2, 2000, Pages 71-82

  Buckland, Andrew G ^a   Wilton, David C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Antimicrobial; Bactericidal permeability increasing protein; Gram negative; Gram positive; Group IIa secreted phospholipase A2; Membrane hydrolysis

Indexed keywords

ACUTE PHASE PROTEIN; AMPHOLYTE; ANION; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CATION; LIPOPOLYSACCHARIDE; PHOSPHOLIPASE A2;

ACUTE PHASE RESPONSE; ANTIBACTERIAL ACTIVITY; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME RELEASE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ACUTE-PHASE PROTEINS; ANIMALS; ANIONS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CELL WALL; ELECTROSTATICS; GRAM-POSITIVE BACTERIA; HUMANS; LACRIMAL APPARATUS; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; PANETH CELLS; PERMEABILITY; PHOSPHOLIPASES A; PHOSPHOLIPIDS; STAPHYLOCOCCAL INFECTIONS;

BACTERIA (MICROORGANISMS); EUKARYOTA; NEGIBACTERIA; POSIBACTERIA;

EID: 0034739437     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(00)00111-6     Document Type: Review

References (70)

1. Extracellular phospholipase-A(2) expression and inflammation - The relationship with associated disease states
2. Regulatory functions of phospholipase A(2)
3. Studies on the acyl-chain selectivity of cellular phospholipases-A2
4. Human nonpancreatic secreted phospholipase-A2 - Interfacial parameters, substrate specificities, and competitive inhibitors
5. Mammalian secreted and cytosolic phospholipase A(2) show different specificities for phospholipid molecular-species
6. Role of cytosolic phospholipase A(2) in allergic response and parturition
7. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A(2)
8. Functional coupling between various phospholipase A(2)s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways
9. 2, with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway
10. Enhanced hydrolysis of phosphatidylcholine by human group-II nonpancreatic secreted phospholipase A(2) as a result of interfacial activation by specific anions - Potential role of cholesterol sulfate
11. The hydrolysis of phosphatidyl-alcohols by phospholipases A(2) - Effect of head group size and polarity
12. Novel intestinal phospholipase-A2 purification and some molecular characteristics
13. Interfacial enzymology of phospholipase-A2
14. Interfacial enzymology of glycerolipid hydrolases - Lessons from secreted phospholipases A(2)
15. High specificity of human secretory class II phospholipase A(2) for phosphatidic acid
16. Cardiolipin hydrolysis by human phospholipases A(2) - The multiple enzymatic activities of human cytosolic phospholipase A(2)
17. Structure of recombinant human rheumatoid arthritic synovial-fluid phospholipase-A2 at 2.2 Å resolution
18. Comparison of the properties of human group-II phospholipase A(2) with other secretory phospholipases
19. Platelet secretory phospholipase A(2) fails to induce rabbit platelet activation and to release arachidonic-acid in contrast with venom phospholipases A(2)
20. Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A(2)
21. Tryptophan-containing mutant of human (group IIa) secreted phospholipase A(2) has a dramatically increased ability to hydrolyse phosphatidylcholine vesicles and cell membranes
22. Roles of Trp(31) in high membrane binding and proinflammatory activity of human group V phospholipase A(2)
23. Effect of lipid composition on lipoprotein lipase activity measured by a continuous fluorescence assay: Effect of cholesterol supports an interfacial surface penetration model
24. Combined effects of sphingomyelin and cholesterol on the hydrolysis of emulsion particle triolein by lipoprotein lipase
25. Structure and properties of a human non-pancreatic phospholipase-A2
26. Utilisation of labelled Escherichia coli as phospholipase substrate
27. Type II secretory phospholipase A(2) associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation
28. Preferential distribution of group-II-like phospholipase-A2 in mononuclear phagocytic-cells in rat spleen and liver
29. Distribution of pancreatic (group-I) and synovial-type (group-II) phospholipases-A(2) in human tissues
30. Secretion of type II phospholipase A(2) and cryptdin by rat small intestinal Paneth cells
31. Secretion of group 2 phospholipase-A2 by lacrimal glands
32. Synthesis of group II phospholipase A2 and lysozyme in lacrimal glands
33. Induction of phospholipase-A2 gene-expression in human hepatoma-cells by mediators of the acute phase response
34. A role for secretory phospholipase A(2) and C-reactive protein in the removal of injured cells
35. Antimicrobial peptides of vertebrates
36. Mapping the interfacial binding surface of human secretory group IIa phospholipase A(2)
37. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense
38. Determinant of the action of phospholipases A on the envelope phospholipids of Escherichia coli
39. The role of phospholipase-A2 lysines in phospholipolysis of Escherichia coli killed by a membrane active neutrophil protein
40. Amino-acid-sequence of a basic Agkistrodon-halys-blomhoffii phospholipase-A2 - Possible role of NH2-terminal lysines in action on phospholipids of Escherichia coli
41. Conversion of pig pancreas phospholipase-A2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal permeability-increasing protein
42. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A(2) in concert with po(C) lymorphonuclear leukocytes
43. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates
44. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of Gram-negative bacteria
45. Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection
46. Extracellular accumulation of potently microbicidal bactericidal permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate
47. Bactericidal properties of murine intestinal phospholipase A(2)
48. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge - Role of group IIA phospholipase A(2)
49. Structural and functional-properties of a phospholipase-A2 purified from an inflammatory exudate
50. Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase-A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate
51. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2
52. Bacterial cell membrane hydrolysis by secreted phospholipases A2: A major physiological role of human group IIa sPLA2 involving both bacterial cell wall penetration and interfacial catalysis
53. Secretory phospholipase A(2) is the principal bactericide for staphylococci and other Gram-positive bacteria in human tears
54. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus
55. Phospholipid synthesis by Staphylococcus aureus during (sub)lethal attack by mammalian 14-kilodalton group IIA phospholipase A2
56. Cell-wall determinants of the bactericidal action of group IIA phospholipase A(2) against Gram-positive bacteria
57. Lysostaphin: Enzymatic mode of action
58. Regulation of bacterial cell walls: Correlation between autolytic activity and cell wall turnover in Staphylococcus aureus
59. Changes in the chemical-structure of walls of Staphylococcus aureus grown in the presence of chloramphenicol
60. Turnover of bacterial cell wall peptidoglycans
61. Identification of endo-beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus
62. Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus
63. Protection by group II phospholipase A(2) against Staphylococcus aureus
64. Immunochemical detection of group-I and group-II phospholipases-A2 in human serum
65. Action of human group IIa secreted phospholipase A(2) on cell membranes - Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme
66. Computer modelling of electrostatic steering and orientational effects in antibody-antigen association
67. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: Stoichiometry, stabilization, and kinetics
68. The electrostatic basis for the interfacial binding of secretary phospholipases A(2)
69. The permeability of the wall fabric of Escherichia coli and Bacillus subtilis
70. Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A(2) from Bothrops asper snake venom - Synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region